Speaker illustration

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)

Alberico Catapano is Full Professor of Pharmacology and Director of the Center of Epidemiology and Preventive Pharmacology at the University of Milan, as well as Director of the Laboratory of Lipoproteins, Immunity and Atherosclerosis and the Center for the Study of Atherosclerosis at Bassini Hospital, and at Multimedica IRCCS Milan, Italy. His main research interests include the study of atherosclerosis, lipids, lipoproteins and genetic dyslipidaemias, and he has made landmark observations regarding heat shock proteins and pentraxins in atherogenesis, on high-density lipoproteins in the modulation of the immune response, and on the identification of possible therapeutic targets by exploiting genetic information. A past President of the European Atherosclerosis Society (EAS), Professor Catapano is currently Co-Chairman of the EAS/European Society of Cardiology (ESC) guidelines for dyslipoproteinaemias, President of the Italian Society of Clinical and Experimental Therapeutics

Diabetes, obesity, and the heart

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session type: Moderated ePosters

Thumbnail

Great Debate: should we still target triglycerides to decrease cardiovascular risk?

Event: ESC Congress 2023

Topic: Lipids

Session type: Great Debates

Thumbnail

Are we achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals in real life?

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Thumbnail

Combination therapy at the heart of lipid lowering management

Event: ESC Preventive Cardiology 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Thumbnail

EAS Consensus on Lp(a) 2022 - what to measure, in whom to measure, how to interpret and what to do

Event: ESC Congress 2022

Topic: Lipids

Session type: Symposium

Thumbnail

Dyslipidemia Challenge - Closing the Gap Between Guidelines and Clinical Practice

Event: ESC Congress 2021 - The Digital Experience

Topic: PCSK9-Antagonists

Session type: Satellite Symposium

Thumbnail

Lipid lowering beyond LDL-cholesterol and statins

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Cardiology Toolbox

Thumbnail

Managing patients with dyslipidaemia: how to tackle clinical inertia

Event: ESC Congress 2020

Topic: Drug therapy

Session type: Industry Q&A session

Thumbnail

Lipid Treatment in very high risk ASCVD patient

Event: ESC Congress 2019

Topic: Lipids

Session type: Symposium

Thumbnail

2019 ESC/EAS Guidelines on Dyslipidaemias

Event: ESC Congress 2019

Topic: Lipids

Session type: New ESC Guidelines

Thumbnail